Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury

生物能衰竭是围产期脑损伤后脑功能障碍的基础

基本信息

  • 批准号:
    9382739
  • 负责人:
  • 金额:
    $ 39.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY ABSTRACT Long-term cognitive impairment and learning disabilities are a major public health concern that affects more than half of infants born very preterm with immature lung injury. Such infants have a global delay in cerebral maturation of gray and white matter structures, likely caused by high susceptibility to hypoxia-induced oxidative stress during this critical period. This stress can result in mitochondrial dysfunction. If mitochondrial-dependent oxidative metabolism is required for immature progenitor cells to mature, then mitochondrial dysfunction can result in failure of timely progenitor cell maturation. Little is known about the metabolic alterations or the dependence of neural progenitor cell maturation on mitochondrial metabolism in the developing brain. Our work will fill this gap in knowledge. We use a rodent model of chronic hypoxia to recapitulate the immature lung injury commonly found in very preterm infants, which causes global gray and white matter cellular dysmaturity and associated ultrastructural and behavioral deficits. In this study, we will investigate the metabolic effects of hypoxia on hippocampal dysmaturation and determine the developmental outcome of mitochondrial disruption. Our preliminary data on the hippocampus indicate that: i) hypoxia causes long-term decreases in biochemical markers of mitochondrial function; ii) hypoxia impairs expression of pyruvate dehydrogenase E1α independent of its inhibitors; and iii) conditional removal of pyruvate dehydrogenase E1α from GFAP-expressing radial glia stem cells prevents their maturation. A potential target for promoting recovery after perinatal brain injury is timely restoration of mitochondrial function and oxidative metabolism. Our published and preliminary data strongly suggest the novel findings that intranasal heparin-binding epidermal growth factor [HB-EGF] treatment after hypoxia may reverse hypoxia-induced cellular dysmaturation, restore mitochondrially produced N-acetyl aspartate, and ameliorate neurobehavioral deficits by targeting the mitochondria. We hypothesize that mitochondrial dysfunction results in delayed development of hippocampal neural progenitor cell capacity to perform oxidative energy metabolism, thus preventing their maturation. We will test the hypothesis that restoring mitochondrial function will enable these cells to meet their bioenergetic demands, permitting timely cellular maturation and recovery of function in the hippocampus. These hypotheses will be tested in three specific aims. In Aim 1, we will determine whether hypoxia impairs mitochondrial function in the hippocampus. In Aim 2, we will determine whether hypoxia or cell-specific removal of pyruvate dehydrogenase E1α in hippocampal neural progenitor cells delays differentiation and hippocampal behavioral deficits. In Aim 3, we will determine whether intranasal HB-EGF treatment after hypoxia enhances mitochondrial function. Successful completion of these aims will elucidate a fundamental biochemical mechanism that determines differentiation failure of neural progenitor cells after hypoxia-induced injury and define a novel metabolic mechanism by which HB-EGF facilitates cellular and functional recovery after neonatal brain injury.
项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph Scafidi其他文献

Joseph Scafidi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph Scafidi', 18)}}的其他基金

Coordination of fatty acid metabolism following neonatal brain injury from preterm birth
早产新生儿脑损伤后脂肪酸代谢的协调
  • 批准号:
    10641924
  • 财政年份:
    2022
  • 资助金额:
    $ 39.4万
  • 项目类别:
Coordination of fatty acid metabolism following neonatal brain injury from preterm birth
早产新生儿脑损伤后脂肪酸代谢的协调
  • 批准号:
    10539030
  • 财政年份:
    2022
  • 资助金额:
    $ 39.4万
  • 项目类别:
Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury
生物能衰竭是围产期脑损伤后脑功能障碍的基础
  • 批准号:
    10240636
  • 财政年份:
    2017
  • 资助金额:
    $ 39.4万
  • 项目类别:
Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury
生物能衰竭是围产期脑损伤后脑功能障碍的基础
  • 批准号:
    10328820
  • 财政年份:
    2017
  • 资助金额:
    $ 39.4万
  • 项目类别:
Mechanisms regulating KCC2 hypofunction during refractory seizures in a mouse model of ischemic neonatal seizures
缺血性新生儿癫痫发作小鼠难治性癫痫发作期间 KCC2 功能低下的调节机制
  • 批准号:
    10205121
  • 财政年份:
    2017
  • 资助金额:
    $ 39.4万
  • 项目类别:
Bioenergetic Failure Underlies Cerebral Dysmaturity After Perinatal Brain Injury
生物能衰竭是围产期脑损伤后脑功能障碍的基础
  • 批准号:
    9752675
  • 财政年份:
    2017
  • 资助金额:
    $ 39.4万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    9098869
  • 财政年份:
    2015
  • 资助金额:
    $ 39.4万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    8091982
  • 财政年份:
    2011
  • 资助金额:
    $ 39.4万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    8436277
  • 财政年份:
    2011
  • 资助金额:
    $ 39.4万
  • 项目类别:
Enhanced EGF Receptor Signaling Prevents White Matter Injury in Perinatal Hypoxia
增强的 EGF 受体信号传导可预防围产期缺氧时的白质损伤
  • 批准号:
    8233981
  • 财政年份:
    2011
  • 资助金额:
    $ 39.4万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 39.4万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了